374 related articles for article (PubMed ID: 30458856)
1. Statin drugs to reduce breast cancer recurrence and mortality.
Beckwitt CH; Brufsky A; Oltvai ZN; Wells A
Breast Cancer Res; 2018 Nov; 20(1):144. PubMed ID: 30458856
[TBL] [Abstract][Full Text] [Related]
2. Statins: a role in breast cancer therapy?
Borgquist S; Bjarnadottir O; Kimbung S; Ahern TP
J Intern Med; 2018 Oct; 284(4):346-357. PubMed ID: 29923256
[TBL] [Abstract][Full Text] [Related]
3. Statins Use and Risk of Breast Cancer Recurrence and Death: A Systematic Review and Meta-Analysis of Observational Studies.
Mansourian M; Haghjooy-Javanmard S; Eshraghi A; Vaseghi G; Hayatshahi A; Thomas J
J Pharm Pharm Sci; 2016; 19(1):72-81. PubMed ID: 27096694
[TBL] [Abstract][Full Text] [Related]
4. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.
Ahern TP; Pedersen L; Tarp M; Cronin-Fenton DP; Garne JP; Silliman RA; Sørensen HT; Lash TL
J Natl Cancer Inst; 2011 Oct; 103(19):1461-8. PubMed ID: 21813413
[TBL] [Abstract][Full Text] [Related]
5. Post-diagnostic statin use and its association with cancer recurrence and mortality in breast cancer patients: a systematic review and meta-analysis.
Jaiswal V; Agrawal V; Ang SP; Saleeb M; Ishak A; Hameed M; Rajak K; Kalra K; Jaiswal A
Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):731-740. PubMed ID: 37562940
[TBL] [Abstract][Full Text] [Related]
6. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
Chao C; Jacobsen SJ; Xu L; Wallner LP; Porter KR; Williams SG
BJU Int; 2013 May; 111(6):954-62. PubMed ID: 23464862
[TBL] [Abstract][Full Text] [Related]
7. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
8. Potentially important considerations in choosing specific statin treatments to reduce overall morbidity and mortality.
Lim S; Sakuma I; Quon MJ; Koh KK
Int J Cardiol; 2013 Sep; 167(5):1696-702. PubMed ID: 23159411
[TBL] [Abstract][Full Text] [Related]
9. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors.
Kwan ML; Habel LA; Flick ED; Quesenberry CP; Caan B
Breast Cancer Res Treat; 2008 Jun; 109(3):573-9. PubMed ID: 17674197
[TBL] [Abstract][Full Text] [Related]
10. The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis.
Liu B; Yi Z; Guan X; Zeng YX; Ma F
Breast Cancer Res Treat; 2017 Jul; 164(1):1-11. PubMed ID: 28432513
[TBL] [Abstract][Full Text] [Related]
11. Statins and breast cancer prognosis: evidence and opportunities.
Ahern TP; Lash TL; Damkier P; Christiansen PM; Cronin-Fenton DP
Lancet Oncol; 2014 Sep; 15(10):e461-8. PubMed ID: 25186049
[TBL] [Abstract][Full Text] [Related]
12. Preventing metastatic emergence of breast cancer.
Wells A; Beckwitt C; Marti JLG
Aging (Albany NY); 2021 Oct; 13(19):22627-22628. PubMed ID: 34633294
[No Abstract] [Full Text] [Related]
13. Statin use and breast cancer survival: a nationwide cohort study from Finland.
Murtola TJ; Visvanathan K; Artama M; Vainio H; Pukkala E
PLoS One; 2014; 9(10):e110231. PubMed ID: 25329299
[TBL] [Abstract][Full Text] [Related]
14. Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins.
Chae YK; Valsecchi ME; Kim J; Bianchi AL; Khemasuwan D; Desai A; Tester W
Cancer Invest; 2011 Nov; 29(9):585-93. PubMed ID: 21936625
[TBL] [Abstract][Full Text] [Related]
15. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
16. Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort.
Nickels S; Vrieling A; Seibold P; Heinz J; Obi N; Flesch-Janys D; Chang-Claude J
PLoS One; 2013; 8(9):e75088. PubMed ID: 24086446
[TBL] [Abstract][Full Text] [Related]
17. Statin use and cancer risk: a comprehensive review.
Boudreau DM; Yu O; Johnson J
Expert Opin Drug Saf; 2010 Jul; 9(4):603-21. PubMed ID: 20377474
[TBL] [Abstract][Full Text] [Related]
18. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
Laleman N; Henrard S; van den Akker M; Goderis G; Buntinx F; Van Pottelbergh G; Vaes B
BMC Cardiovasc Disord; 2018 Nov; 18(1):209. PubMed ID: 30400778
[TBL] [Abstract][Full Text] [Related]
19. Statins and immunotherapy: Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC.
Rossi A; Filetti M; Taurelli Salimbeni B; Piras M; Rizzo F; Giusti R; Marchetti P
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1368. PubMed ID: 33788420
[TBL] [Abstract][Full Text] [Related]
20. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.
Bjarnadottir O; Romero Q; Bendahl PO; Jirström K; Rydén L; Loman N; Uhlén M; Johannesson H; Rose C; Grabau D; Borgquist S
Breast Cancer Res Treat; 2013 Apr; 138(2):499-508. PubMed ID: 23471651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
